Search

Your search keyword '"Vlieghe, Erika"' showing total 328 results

Search Constraints

Start Over You searched for: Author "Vlieghe, Erika" Remove constraint Author: "Vlieghe, Erika"
328 results on '"Vlieghe, Erika"'

Search Results

6. Proline-specific peptidase activities (DPP4, PRCP, FAP and PREP) in plasma of hospitalized COVID-19 patients

8. Low TB-treatment initiation after positive TB-LAM results

11. Personalized bacteriophage therapy outcomes for 100 consecutive cases:a multicentre, multinational, retrospective observational study

13. Implementation of the advanced HIV disease care package with point-of-care CD4 testing during tuberculosis case finding: A mixed-methods evaluation

16. Clinical Management of Argentine Hemorrhagic Fever using Ribavirin and Favipiravir, Belgium, 2020

17. Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells

18. Scientific advisory councils in the COVID-19 response

19. Clinical bacteriology in low-resource settings: today's solutions

20. A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

21. Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

24. The emergence of travel-related infections in critical care units

25. Diagnosing Viral Infections Through T-Cell Receptor Sequencing of Activated CD8+ T Cells.

26. Scientific advisory councils in the COVID-19 response

27. Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review/Revue systematique des interventions visant a promouvoir une utilization rationnelle des antibiotiques en milieu hospitalier, dans les pays a revenu faible et intermediaire/Intervenciones de administracion de antibioticos en hospitales de paises con ingresos bajos y medios: una revision sistematica

28. Leveraging T-cell receptor – epitope recognition models to disentangle unique and cross-reactive T-cell response to SARS-CoV-2 during COVID-19 progression/resolution

30. Risk of Misinterpretation of Ebola Virus PCR Results After rVSV ZEBOV-GP Vaccination

33. Antibiotic resistance—the need for global solutions

34. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries

35. Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso

36. Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso

37. Antibiotic prescription behaviours in Lao People's Democratic Republic: a knowledge, attitude and practice survey/Comportement en matiere de prescription des antibiotiques en Republique democratique populaire lao: une etude sur la connaissance, l'attitude et la pratique/Conductas en la prescripcion de antibioticos en la Republica Democratica Popular Lao: una encuesta sobre conocimientos, actitudes y practicas

38. Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis

39. Scientific advisory councils in the COVID-19 response

40. Use of WATCH antibiotics prior to presentation to the hospital in rural Burkina Faso

43. Additional file 4 of Assessing the impact of the Global Point Prevalence Survey of Antimicrobial Consumption and Resistance (Global-PPS) on hospital antimicrobial stewardship programmes: results of a worldwide survey

47. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries

48. Melioidosis, Phnom Penh, Cambodia

49. Additional file 4 of A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

50. Additional file 3 of A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial

Catalog

Books, media, physical & digital resources